SCHEMBL13083301

SCHEMBL13083301

C/C(=N\c1ccc(C(C)C)cc1)N(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
NOS1 P29475 7/20 0.46
NOS3 P29474 6/20 0.46
NOS2 P35228 5/20 0.46
CYP2C9 P11712 1/20 0.43
PRSS1 P07477 1/20 0.40
ACR P10323 1/20 0.40
SCN5A Q14524 1/20 0.39
SCN2A Q99250 1/20 0.39
HTT P42858 1/20 0.35
TYR P14679 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20173404 0.82 CYP2C9 (0.49) ALDH1A1NOS1NOS3NOS2CYP2C9
SCHEMBL11733750 0.79 NOS1 (0.59) ALDH1A1SMN1; SMN2NOS1NOS3NOS2
SCHEMBL11733757 0.79 NOS1 (0.59) ALDH1A1SMN1; SMN2NOS1NOS3NOS2
SCHEMBL24227104 0.78 NOS1 (0.37) ALDH1A1SMN1; SMN2GRIN2DGRIN3BGRIN1
SCHEMBL15159798 0.77 HTR3E (0.52) ALDH1A1SMN1; SMN2GRIN2DGRIN3BGRIN1
SCHEMBL15153262 0.77 HTR3E (0.52) ALDH1A1SMN1; SMN2GRIN2DGRIN3BGRIN1
SCHEMBL20175858 0.77 ADRA2A (0.49) ALDH1A1SMN1; SMN2NOS1NOS3NOS2
SCHEMBL7260907 0.74 NOS1 (0.56) ALDH1A1NOS1NOS3NOS2TSHR
SCHEMBL7260909 0.74 NOS1 (0.56) ALDH1A1NOS1NOS3NOS2TSHR
SCHEMBL10341822 0.71 NOS1 (0.50) ALDH1A1NOS1NOS3NOS2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283385-B2 Emulsion polymerization; oil industry QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-10-09 US disclosed
US-20080197084-A1 Reversibly switchable surfactants and methods of use thereof QUEEN'S UNIVERSITY AT KINGSTON (CA) 2008-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080197084-A1 Reversibly switchable surfactants and methods of use thereof SGMS1, SGMS2, HDHD5 ALDH1A1 3854/4885SMN1; SMN2 1597/4885GRIN2D 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.